nodes	percent_of_prediction	percent_of_DWPC	metapath
Lornoxicam—PTGS2—nephron—ureter cancer	0.345	0.345	CbGeAlD
Lornoxicam—CYP2C9—urine—ureter cancer	0.317	0.317	CbGeAlD
Lornoxicam—PTGS1—renal system—ureter cancer	0.0708	0.0708	CbGeAlD
Lornoxicam—PTGS1—kidney—ureter cancer	0.0684	0.0684	CbGeAlD
Lornoxicam—PTGS2—renal system—ureter cancer	0.0676	0.0676	CbGeAlD
Lornoxicam—PTGS2—urethra—ureter cancer	0.0664	0.0664	CbGeAlD
Lornoxicam—PTGS2—kidney—ureter cancer	0.0654	0.0654	CbGeAlD
